Inventor
ANDERSON KEVIN P
US16 patents
⚠️ This page may combine multiple inventors who share the name “ANDERSON KEVIN P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ISIS PHARMACEUTICALS INC
13 patentsUS6174868B1Jan 16, 2001
Compositions and methods for treatment of hepatitis C virus-associated diseases
ISIS PHARMACEUTICALS INC141 citations98
US5789573AAug 4, 1998
Antisense inhibition of ICAM-1, E-selectin, and CMV IE1/IE2
ISIS PHARMACEUTICALS INC262 citations98
US5514577AMay 7, 1996
Oligonucleotide therapies for modulating the effects of herpes viruses
ISIS PHARMACEUTICALS INC153 citations98
US6433159B1Aug 13, 2002
Compositions and methods for treatment of Hepatitis C virus associated diseases
ISIS PHARMACEUTICALS INC67 citations96
US6423489B1Jul 23, 2002
Compositions and methods for treatment of Hepatitis C virus-associated diseases
ISIS PHARMACEUTICALS INC120 citations96
US6391542B1May 21, 2002
Compositions and methods for treatment of Hepatitis C virus-associated diseases
ISIS PHARMACEUTICALS INC95 citations96
US6284458B1Sep 4, 2001
Compositions and methods for treatment of hepatitis C virus-associated diseases
ISIS PHARMACEUTICALS INC87 citations96
US5591720AJan 7, 1997
Oligonucleotides for modulating the effects of cytomegalovirus infections
ISIS PHARMACEUTICALS INC83 citations96
US5952490ASep 14, 1999
Oligonucleotides having a conserved G4 core sequence
ISIS PHARMACEUTICALS INC69 citations94
US6608191B1Aug 19, 2003
Compositions and methods for treatment of hepatitis C virus-associated diseases
ISIS PHARMACEUTICALS INC34 citations92
US5985662ANov 16, 1999
Antisense inhibition of hepatitis B virus replication
ISIS PHARMACEUTICALS INC47 citations92
US6995146B2Feb 7, 2006
Compositions and methods for treatment of hepatitis C virus-associated diseases
ISIS PHARMACEUTICALS INC26 citations88
US6153595ANov 28, 2000
Composition and method for treatment of CMV infections
ISIS PHARMACEUTICALS INC8 citations68